Clinical Trial Update: Oral Cannabidiol for Tobacco Cessation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating oral cannabidiol for tobacco cessation is currently recruiting, sponsored by Johns Hopkins University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Johns Hopkins University | Conditions: Tobacco Use, Tobacco Smoking | Phase 1 | Status: RECRUITING